NTRK1 and breast cancer: These effects are most likely due to the activation of the TrkA/Ras/MAPK cascade [90], as well as the NGF-induced phosphorylation of P185HER2 [100], a kinase receptor per se, which are overexpressed in breast cancer cells and also stimulate their cell growth through the MAPK pathway [104,105,106].